Ivaford 5mg Tablet contains Ivabradine, a selective sinus node inhibitor used primarily for the treatment of chronic stable angina pectoris and heart failure. Ivabradine acts by specifically inhibiting the If current in the sinoatrial node, resulting in heart rate reduction without affecting myocardial contractility or intracardiac conduction. This mechanism helps decrease myocardial oxygen demand, thereby alleviating symptoms of angina and improving exercise tolerance. Ivaford is indicated in patients with stable angina who are in sinus rhythm and have a contraindication or intolerance to beta-blockers or as an adjunct to beta-blocker therapy when heart rate control is inadequate. Additionally, it is prescribed for patients with chronic heart failure with reduced ejection fraction (HFrEF) who remain symptomatic despite optimal standard therapy, including beta-blockers, to reduce the risk of hospitalization. The recommended dose is individualized based on heart rate response, with careful monitoring to avoid bradycardia. Ivaford should be used cautiously in patients with atrial fibrillation, severe hepatic impairment, or pacemaker dependency. Common adverse effects include bradycardia, luminous phenomena (phosphenes), and headache. Ivaford is contraindicated in acute decompensated heart failure, hypotension, and severe bradycardia. Regular cardiac monitoring is advised during treatment to ensure safety and efficacy.